Feb 3, 2026
UPMC Experts Lead Conversations on Health Care Innovation Across Early 2026 Events
UPMC and UPMC Enterprises leaders are engaging across national and regional industry events to help shape the future of digital innovation, AI, precision medicine, clinical trials, and more in early 2026.
Our lineup of event engagements in the first quarter of 2026 highlights a clear theme: UPMC Enterprises experts are influencing the conversations that will define key moments in the future of health care — particularly in areas where clinical excellence, data, AI, and patient-centered innovation converge.
A number of our portfolio companies will also be onsite at select events, reinforcing how our investments translate into meaningful contributions to the health care innovation landscape.
We invite you to view our full event list below to learn more about our participation.
2026 Digital Health Summit | Jan. 29 – 30, Pittsburgh, PA
At the 2026 Digital Health Summit, Fawad Butt, CEO of Penguin Ai, a UPMC Enterprises portfolio company, served as a keynote speaker of the event and joined Rob Bart, MD, CMIO of UPMC, on a panel addressing the tie between AI and precision medicine. Chris Carmody, CTO, UPMC, also presented as part of the “local innovation” spotlight series.
SCOPE Summit | Feb. 2-5, Orlando, FL
Andrew Adrian-Karlin, director of Technology Services Pipeline Development, attended on behalf of UPMC Enterprises to connect with industry peers and share updates on the Ahavi real‑world data platform and related partnership opportunities.
3 Rivers Venture Fair (3RVF) | Feb. 4 – 5, Pittsburgh, PA
Deepan Kamaraj, MD, PhD, director of Data Analytics and Informatics at UPMC Enterprises, spoke on a panel titled “Data Privacy & AI Governance Polices – What to Expect When You Go to Market” at 3RVF, a Pittsburgh-based venture capital event connecting high-growth startups with investors, corporate partners, and innovation leaders. UPMC Enterprises served as an official sponsor at the event.
Life Sciences PA “Being a Life Sciences Leader” Podcast | Feb. 4
We’re proud to share that Jeanne Cunicelli, executive vice president at UPMC and president of UPMC Enterprises, was recently featured on the “Being a Life Sciences Leader” podcast from Life Sciences Pennsylvania. In the conversation, Jeanne discusses how UPMC Enterprises translates innovation into real-world impact by bringing together clinical insight, research excellence, and global perspective. From AI and digital health to life sciences and translational medicine, the episode highlights how our work is helping shape what’s next in health care for patients, providers, and the broader ecosystem. Listen to the full conversation here.
Anna Mamo, director, Translational Sciences, will join a virtual roundtable discussion hosted by Women’s Health Access Matters (WHAM), on Thursday, Feb. 19, at 1 p.m. EST. In recognition of National American Heart Month, the discussion will focus on the challenges and opportunities within women’s cardiovascular health.
Anna will join fellow health care leaders Carolee Lee, CEO & Founder, WHAM; Dr. Albert Kim, CMO, Imbria Pharmaceuticals; Dr. Stacey Rosen, executive director, Katz Institute for Women’s Health, SVP, women’s health, Northwell Health, and volunteer president, AHA; and Dr. Basmah Safdar, professor of emergency medicine and director, women’s health research at Yale, on the panel titled “Women’s Heart Health: What We’re Missing and Why It Matters.” Register today using this link.
ViVE 2026 | Feb. 22 – 25, Los Angeles, CA
UPMC and UPMC Enterprises will also maintain a strong presence at ViVE 2026, with David Okonkwo, MD, PhD, executive vice president of UPMC Enterprises, speaking on a panel titled “Clinical Trials Without the Wait, Waste & Wonder,” and Rob Bart, MD, CMIO of UPMC, participating in a panel session titled “EHR Maturity Moment.”
In addition, a number of UPMC Enterprises portfolio companies will also be onsite in Los Angeles. Four portfolio companies, Abridge, Clearsense, Parachute Health, and Percipio Health, are serving as sponsors of the event.
Panel presentations from our portfolio companies include:
Monday, Feb. 23 | Innovation Theater C | 3:40 p.m. – 4 p.m.
Mike Tiemeyer, CISO, Butterfly Network, will be featured on a panel titled “Beyond HIPAA: Developing a Comprehensive Compliance Strategy”
Monday, Feb. 23 | Palm Stage| 4:30 p.m. – 5 p.m.
Jason Rose, CEO, Clearsense, will speak alongside colleagues on the “IT Cost Optimization & Enterprise Strategy”
Tuesday, Feb. 24 | West Coast Stage | 9:40 a.m. – 10:05 a.m.
Shiv Rao, MD, UPMC cardiologist and CEO and co-founder of Abridge will join Doximity for a discussion titled “Not Another One-Trick Pony: What It Takes to Build Enduring AI in Healthcare”
Tuesday, Feb. 24 | Palm Stage | 2:20 p.m. – 3 p.m.
Guru Sundar, VP of Marketing at Abridge, moderating the panel, “Pilot to Platform: Building Responsible, Systemwide AI That Works”
Tuesday, Feb. 24 | Sunset Stage | 3:30 p.m. – 4:10 p.m.
Julia Chou, Chief Operating Officer of Abridge, speaking on “The Cure for AI Short-Sightedness” panel
Other portfolio attendees include Redesign Health and Koda Health.
Also at ViVE, UPMC Enterprises will proudly partner with the Digital Medicine Society (DiMe) — also an event sponsor — to spotlight Ahavi in the DiMe Pavilion, giving attendees an exclusive opportunity to learn more about partnerships and benefits of UPMC Enterprises’ real-world data platform.
Additionally, Andrew Adrian-Karlin, director, Technology Services Pipeline Development, UPMC Enterprises, will serve as a panelist for the closing fireside in DiMe’s partner program at ViVE “When AI Goes Live: Governance Benchmarks for the Real World” on Monday, Feb. 23, at 10:30 a.m.
Clinical Trial Billing and Compliance Summit | Feb. 23 – 25, New Orleans, LA
Soun Khountham, senior director of Sponsored Clinical Trials and Partnerships, will attend this event on behalf of UPMC Enterprises, engaging with peers on key topics shaping the clinical trials industry and sharing updates on UPMC’s evolving sponsored clinical trials and partnerships work.
Women in Bio (WIB) Pittsburgh Life Sciences Resource Fair | Feb. 26, Pittsburgh, PA
Mary Beth Navarra-Sirio, vice president, Market Development, is a featured speaker at the Women in Bio (WIB) Pittsburgh Life Sciences Resource Fair on Thursday, Feb. 26, from 5:30 to 8 p.m. Hosted by Executive Women In Bio (EWIB), LifeX, and InnovatePGH, Mary Beth’s presentation will focus on “putting together your innovation dream team, how choosing the right partners accelerates progress.”
Transforming Healthcare Management Through AI: Opportunities and Challenges | Feb. 27, Pittsburgh, PA
Deepan Kamaraj, MD, PhD, director of Data Analytics and Informatics at UPMC Enterprises, will be part of a panel titled “Entrepreneurship in the Health and AI Space,” alongside Megan Shaw, president and CEO of the Pittsburgh Life Sciences Association, and other prominent colleagues for a discussion focused on innovation pathways, commercialization challenges, and opportunities emerging at the intersection of AI and health care.
Precision Medicine World Conference (PMWC) | Mar. 4 – 6, Santa Clara, CA
Adrian Lee, PhD, senior advisor to UPMC Enterprises, and the director of the Institute for Precision Medicine, a joint effort by UPMC and the University of Pittsburgh, will serve as the Track Chair for the Liquid Biopsy – Therapy Guidance & Monitoring track, a notable leadership position for UPMC within a major national precision medicine forum.
Next Steps
- Learn more about UPMC Enterprises portfolio of translational sciences and digital health companies.
*UPMC Enterprises has a financial interest in Abridge, Butterfly Network, Clearsense, Parachute Health, Percipio Health, Penguin Ai, and Glimmer Health.
